ATXI

Avenue Therapeutics (ATXI)

About Avenue Therapeutics (ATXI)

Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.

Details

Daily high

$2.06

Daily low

$1.92

Price at open

$1.99

52 Week High

$45.75

52 Week Low

$1.90

Market cap

2.9M

Dividend yield

0.00%

Volume

6,920

Avg. volume

23,388

P/E ratio

-.27

Avenue Therapeutics News